Laurion Capital Management LP Q4 2022 Filing
Filed February 14, 2023
Portfolio Value
$21.4B
Holdings
256
Report Date
Q4 2022
Filing Type
13F-HR
All Holdings (256 positions)
| # | Stock | Shares | Value | % Portfolio | Type |
|---|---|---|---|---|---|
| 201 | RWAYRUNWAY GROWTH FINANCE CORP | 70,898 | $821.7M | 3.84% | |
| 202 | —CODIAK BIOSCIENCES INC | 2,013,300 | $800.5M | 3.74% | |
| 203 | LYFTLYFT INC | 65,500 | $721.8M | 3.37% | Call |
| 204 | KALVKALVISTA PHARMACEUTICALS INC | 99,015 | $669.3M | 3.13% | |
| 205 | MEIPUSDMEI PHARMA INC | 2,576,900 | $627.7M | 2.93% | |
| 206 | TBLATABOOLA.COM LTD | 200,000 | $616.0M | 2.88% | |
| 207 | CYTCYTEIR THERAPEUTICS INC | 359,500 | $593.2M | 2.77% | |
| 208 | XLFSELECT SECTOR SPDR TR | 17,100 | $584.8M | 2.73% | |
| 209 | MBIOUSDMUSTANG BIO INC | 1,445,600 | $570.9M | 2.67% | |
| 210 | SURFUSDSURFACE ONCOLOGY INC | 665,400 | $545.6M | 2.55% | |
| 211 | ICEINTERCONTINENTAL EXCHANGE IN | 5,000 | $513.0M | 2.40% | |
| 212 | —FREEDOM ACQUISITION I CORP | 50,000 | $505.0M | 2.36% | |
| 213 | —DMY TECHNOLOGY GROUP INC VI | 50,000 | $502.5M | 2.35% | |
| 214 | —CORSAIR PARTNERING CORP | 50,000 | $500.0M | 2.34% | |
| 215 | CTVINNOVID CORP | 290,305 | $496.4M | 2.32% | |
| 216 | FDMT4D MOLECULAR THERAPEUTICS IN | 21,401 | $475.3M | 2.22% | |
| 217 | PRAXPRAXIS PRECISION MEDICINES I | 196,669 | $468.1M | 2.19% | |
| 218 | —IMPEL PHARMACEUTICALS INC | 124,800 | $468.0M | 2.19% | |
| 219 | RNAAVIDITY BIOSCIENCES INC | 20,000 | $443.8M | 2.07% | |
| 220 | BCELATRECA INC | 492,200 | $394.1M | 1.84% | |
| 221 | XLOXILIO THERAPEUTICS INC | 142,900 | $384.4M | 1.80% | |
| 222 | XLYSELECT SECTOR SPDR TR | 2,700 | $348.7M | 1.63% | |
| 223 | IONQIONQ INC | 100,000 | $345.0M | 1.61% | |
| 224 | MXLMAXLINEAR INC | 10,000 | $339.5M | 1.59% | |
| 225 | DAWNDAY ONE BIOPHARMACEUTICALS I | 15,000 | $322.8M | 1.51% | |
| 226 | VALNVALNEVA SE | 25,000 | $320.0M | 1.50% | |
| 227 | —SQZ BIOTECHNOLOGIES CO | 431,400 | $319.2M | 1.49% | |
| 228 | LVLNSPDR SER TR | 5,300 | $311.3M | 1.46% | |
| 229 | —TALARIS THERAPEUTICS INC | 298,422 | $304.4M | 1.42% | |
| 230 | NMTRQ9 METERS BIOPHARMA INC | 227,910 | $287.2M | 1.34% | |
| 231 | HRTXHERON THERAPEUTICS INC | 114,817 | $287.0M | 1.34% | |
| 232 | INZYINOZYME PHARMA INC | 271,800 | $285.4M | 1.33% | |
| 233 | UBERUBER TECHNOLOGIES INC | 11,405 | $282.0M | 1.32% | |
| 234 | TORCEURADICET BIO INC | 31,518 | $281.8M | 1.32% | |
| 235 | APLTAPPLIED THERAPEUTICS INC | 345,900 | $262.9M | 1.23% | |
| 236 | HONHONEYWELL INTL INC | 1,199 | $256.9M | 1.20% | |
| 237 | —MAGENTA THERAPEUTICS INC | 582,300 | $230.0M | 1.08% | |
| 238 | GLTOUSDGALECTO INC | 190,652 | $219.3M | 1.02% | |
| 239 | —APPLIED MOLECULAR TRANS INC | 481,600 | $202.3M | 0.95% | |
| 240 | —THUNDER BRIDGE CAP PRTNRS II | 20,000 | $195.2M | 0.91% | |
| 241 | UNBXUNITY BIOTECHNOLOGY INC | 70,000 | $191.8M | 0.90% | |
| 242 | VELVELOCITY FINL INC | 13,553 | $130.8M | 0.61% | |
| 243 | OPTEYOPTHEA LTD | 22,652 | $126.9M | 0.59% | |
| 244 | ERASERASCA INC | 23,100 | $99.6M | 0.47% | |
| 245 | —LONGBOARD PHARMACEUTICALS IN | 20,918 | $66.1M | 0.31% | |
| 246 | TBLATABOOLA.COM LTD | 85,000 | $41.6M | 0.19% | |
| 247 | —FINCH THERAPEUTICS GROUP INC | 58,000 | $27.8M | 0.13% | |
| 248 | —DECIBEL THERAPEUTICS INC | 11,990 | $24.6M | 0.11% | |
| 249 | IONQ/WSIONQ INC | 25,000 | $18.2M | 0.09% | |
| 250 | DTILPRECISION BIOSCIENCES INC | 13,267 | $15.8M | 0.07% | |
| 251 | NAMSNEWAMSTERDAM PHARMA COMPANY | 16,666 | $13.3M | 0.06% | |
| 252 | —INNOVID CORP | 25,000 | $10.0M | 0.05% | |
| 253 | —CORSAIR PARTNERING CORP | 16,666 | $5.5M | 0.03% | |
| 254 | —DMY TECHNOLOGY GROUP INC VI | 25,000 | $2.6M | 0.01% | |
| 255 | —FREEDOM ACQUISITION I CORP | 12,500 | $2.5M | 0.01% | |
| 256 | RGTIWRIGETTI COMPUTING INC | 10,000 | $828K | 0.00% |
PreviousPage 3 of 3